Jupiter Asset Management Ltd. bought a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The fund bought 976,446 shares of the company’s stock, valued at approximately $66,037,000.
A number of other hedge funds have also bought and sold shares of CTVA. Activest Wealth Management raised its stake in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after buying an additional 200 shares during the last quarter. True Wealth Design LLC boosted its position in Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares in the last quarter. Total Investment Management Inc. acquired a new stake in shares of Corteva during the 2nd quarter worth approximately $27,000. Curat Global LLC increased its holdings in shares of Corteva by 93.7% during the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after purchasing an additional 179 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in shares of Corteva in the 2nd quarter valued at $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts recently commented on the stock. JPMorgan Chase & Co. lowered shares of Corteva from an “overweight” rating to a “neutral” rating and raised their price target for the company from $75.00 to $77.00 in a research report on Thursday, February 5th. Oppenheimer set a $86.00 price objective on Corteva in a report on Thursday, February 5th. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 22nd. Argus upgraded Corteva to a “strong-buy” rating in a research report on Friday, January 16th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $82.30.
Corteva Price Performance
CTVA stock opened at $77.00 on Friday. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The firm has a market capitalization of $51.78 billion, a PE ratio of 48.74, a price-to-earnings-growth ratio of 2.61 and a beta of 0.75. The business has a 50 day simple moving average of $70.51 and a 200-day simple moving average of $68.57.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 45.57%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Stories
- Five stocks we like better than Corteva
- 3 Signs You May Want to Switch Financial Advisors
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- NEW LAW: Congress Approves Setup For Digital Dollar?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
